DETECTION OF RESIDUAL LUNG CANCER CELLS BY PCR-BASED GENETIC TESTING FOR ROS1-TRANSLOCATION: CASE REPORT

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2018-64-3-331-334

Published 01.03.2018

Fedor Moiseenko⁺⁻
Vladislav Tyurin⁺⁻
Nikita Levchenko⁺⁻
Yevgeniy Levchenko⁺⁻
Aglaya Ievleva⁺⁻
Yevgeniy Imyanitov⁺⁻
Natalya Mityushkina⁺⁻

Fedor Moiseenko

St. Petersburg Clinical Scientific and Practical Center of Specialized Medical Care (Oncology), I.I. Mechnikov North-West State Medical University

Vladislav Tyurin

N.N. Petrov National Medical Research Center of Oncology

Nikita Levchenko

N.N. Petrov National Medical Research Center of Oncology

Yevgeniy Levchenko

I.I. Mechnikov North-West State Medical University, N.N. Petrov National Medical Research Center of Oncology

Aglaya Ievleva

N.N. Petrov National Medical Research Center of Oncology, St. Petersburg State Pediatric Medical University

Yevgeniy Imyanitov

I.I. Mechnikov North-West State Medical University, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg State Pediatric Medical University

Natalya Mityushkina

N.N. Petrov National Medical Research Center of Oncology

##article.numberofdownloads## 33

##article.numberofviews## 147

PDF (Русский)

Keywords

LUNG CANCER
ТРАНСЛОКАЦИЯ ROS1
ROS1-TRANSLOCATION
CRIZOTINIB

How to Cite

Moiseenko, F., Tyurin, V., Levchenko, N., Levchenko, Y., Ievleva, A., Imyanitov, Y., & Mityushkina, N. (2018). DETECTION OF RESIDUAL LUNG CANCER CELLS BY PCR-BASED GENETIC TESTING FOR ROS1-TRANSLOCATION: CASE REPORT. Voprosy Onkologii, 64(3), 331–334. https://doi.org/10.37469/0507-3758-2018-64-3-331-334

Abstract

A patient with lung cancer carrying ROS1 translocation was treated by crizotinib and then subjected to surgery. Morphological analysis revealed pathologic complete response in surgically removed tissues, while PCR test provided convincing evidence for the presence of residual tumor cells. PCR analysis of lung cancer specific gene translocations allows carrying out highly sensitive and reliable monitoring of tumor disease during the course of treatment.

https://doi.org/10.37469/0507-3758-2018-64-3-331-334

##article.numberofdownloads## 33

##article.numberofviews## 147

PDF (Русский)

References

Bayliss R., Choi J., Fennell D. A. et al. Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs // Cellular and molecular life sciences. - 2016. - Vol. 73 (6). - P. 1209-1224.

Cha Y. J., Kim H. R., shim H. s. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants // Journal of translational medicine. - 2016. - Vol. 14 (1). - P. 296.

Heuckmann J. M. et al. Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants // Clinical Cancer Research. - 2012. - Vol. 18 (17). - P. 4682-4690.

Kim H. et al. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression // Journal of Thoracic Oncology. - 2011. - Vol. 6 (8). - P. 13591366.

Kohno T. et al. Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer // Translational lung cancer research. - 2015. - Vol. 4 (2). - P. 156.

Iyevleva A.G., Raskin G.A., Tiurin V.I. et al. Novel ALK fusion partners in lung cancer //Cancer Lett. - 2015. - Vol. 362 (1). - P. 116-121.

Wang R. et al. The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers // Clinical Cancer Research. - 2012. - Vol. 18 (17). - P. 47254732.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Lev Bershteyn, Aleksandr Ivantsov, Aglaya Ievleva, A. Venina, I. Berlev, STEROID RECEPTOR PHENOTYPE, EXPRESSION OF HER-2/NEU, PD-1, PD-L1 AND LYMPHOCYTIC-MACROPHAGAL INFILTRATION OF ENDOMETRIAL CARCINOMAS: COMPARISON OF MODERN MOLECULAR BIOLOGICAL TYPES OF THE DISEASE (THE ROLE OF BODY MASS INDEX) , Voprosy onkologii : Vol. 66 No. 1 (2020)
Svetlana Bekhtereva, Yevgeniy Imyanitov, Andrey Vazhenin, Alla Domozhirova, Irina Aksenova, S. Pshichenko, EPIDEMIOLOGICAL ASPECTS OF OVARIAN CANCER IN THE STRUCTURE OF PRIMARY MULTIPLE MALIGNANT TUMORS OF THE FEMALE REPRODUCTIVE SYSTEM (ON THE EXAMPLE OF THE CHELYABINSK REGION) , Voprosy onkologii : Vol. 64 No. 6 (2018)
Stepan Yergnyan, Yevgeniy Levchenko, I. Kubekov, INDUCTION THERAPY AND METHODS OF PREVENTING THE DEVELOPMENT OF BRONCHOPLEURAL FISTULA IN LOCALLY ADVANCED FORMS OF NON-SMALL CELL LUNG CANCER , Voprosy onkologii : Vol. 64 No. 3 (2018)
Aleksandr Mikhnin, Yevgeniy Levchenko, Oleg Mamontov, P. Kalinin, K. Senchik, ChZhAN VEN, VAN TIN, A. Myasnikov, BIOPHISICAL MODEL OF ISOLATED LUNG CHEMOPERFUSION AND PHARMACOKINETICS OF CISPLATIN , Voprosy onkologii : Vol. 64 No. 6 (2018)
Lev Bershteyn, Igor Berlev, Aglaya Ievleva, Aleksandr Ivantsov, A. Baltrukova, REMODELING OF THE VIEWS ON ENDOMENTRIAL CANCER: SIGNS AND REALITY , Voprosy onkologii : Vol. 64 No. 1 (2018)
Yevgeniy Levchenko, Aleksandr Mikhnin, Stepan Yergnyan, Aleksey Barchuk, Leonid Gorokhov, Yevgeniy Slugin, Marina Grinkevich, Ye. Levchenko, R. Yurin, LONG-TERM RESULTS OF BRONCHOPLASTIC SURGICAL INTERVENTIONS IN COMPARISON WITH PNEUMONECTOMIES IN LUNG CANCER , Voprosy onkologii : Vol. 63 No. 2 (2017)
Galina Kireeva, Yekaterina Gubareva, Natalya Mityushkina, Andrey Panchenko, Mikhail Maydin, Margarita Tyndyk, I. Gavrilov, Stepan Kruglov, Yevgeniya Kharchenko, Vladimir Anisimov, THE STUDY OF CIRCADIAN RHYTHMS IN OVARIAN CANCER RAT MODEL: IS THERE CONNECTION BETWEEN TUMOR DEVELOPMENT AND RHYTHMICITY DISRUPTION IN INTACT TISSUES? , Voprosy onkologii : Vol. 65 No. 6 (2019)
Lev Bershteyn, Aglaya Ievleva, Tatyana Poroshina, Irina Kovalenko, COMPARATIVE FEATURES OF ENDOMETRIAL CANCER PATIENTS WITH A "STANDARD" AND "METABOLICALLY HEALTHY" OBESITY: GENETIC AND GENOTOXIC ASPECT , Voprosy onkologii : Vol. 63 No. 1 (2017)

<< < 1 2 3